Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset is a dataset published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0.629, placing it in the top 31.4% of the data-sharing corpus. It has been cited 28 times, with 25 citing works in its 1-hop citation network. Its calibrated FAIR score is 58/100.
Ranks in the top 31% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“https://dss.niagads.org/datasets/ng00067/”
The strongest identifier given is a web URL, which is not a persistent-identifier scheme (class 2). [majority verdict 'partial' (4/5 passes agreed)]
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“Data is publicly available at NIAGADS Data Storage Site”
The paper explicitly names NIAGADS (National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site) as the repository holding the data.
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“The ADSP R4 dataset of > 347 million variants is available to qualified investigators at https://dss.niagads.org/datasets/ng00067/”— not found in the paper; verdict downgraded
The dataset identifier (ng00067) appears only in the body text, not in the reference list. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (4/5 passes agreed)]
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“The ADSP R4 dataset of > 347 million variants is available to qualified investigators at https://dss.niagads.org/datasets/ng00067/”— not found in the paper; verdict downgraded
The statement points directly to a specific repository record (the dataset page), which is Colavizza category 3. [downgraded to 'partial' — no verifiable quote from the paper]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“TABLE 2 ADSP R4 released file set. All files are available under https://dss.niagads.org/datasets/ng00067/ . Both individual (CRAMs, gVCFs, SV VCFs, and phenotypes) and summary level files (VCFs, GDS, annotation files) are available.”
The paper includes an itemized table (Table 2) that lists the files and their descriptions, forming a structured inventory of the dataset. [majority verdict 'yes' (3/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“Principal investigators can request DSS-distributed data through the Data Access Request Management (DARM) system by logging in using their eRA Commons ID. Once an application is approved by the NIH-formed NIAGADS ADRD Data Access Committee (NADAC) and Data Use Committee (DUC), the data can be accessed through the Data Portal and downloaded directly or through Amazon EC2.”
The text describes a defined, followable access process with a precondition (application and approval by a committee). [majority verdict 'partial' (4/5 passes agreed)]
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“all genomic data are classified as controlled access”
The paper explicitly labels the data as 'controlled access' in the text.
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“NIAGADS ADRD Data Access Committee (NADAC) and Data Use Committee (DUC)”
The paper names an institutional Data Access Committee and Data Use Committee as the gatekeepers for the controlled-access data.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
“Data is publicly available at NIAGADS Data Storage Site”
The paper states the data are available now but does not specify how long they will persist, so only availability timing is given. [majority verdict 'partial' (3/5 passes agreed)]
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
“NIAGADS receives genomes in FASTQ, Binary Alignment Map (BAM), or CRAM (compressed version of BAM) formats”
The paper names open, community-standard formats (FASTQ, BAM, CRAM) for the genomic data. [majority verdict 'yes' (3/5 passes agreed)]
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No named data or metadata community standard (e.g., MIAME, BIDS, GO) is mentioned in the text.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
“The gnomAD resource (version 4) was download from https://gnomad.broadinstitute.org/downloads#v4”
The paper gives a URL identifier for a resource (gnomAD) that is not the paper's own dataset. [majority verdict 'yes' (3/5 passes agreed)]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No licence for the data itself is named; the only licence mentioned is the CC BY-NC 4.0 for the article, which is explicitly excluded per the rules.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“release 4 (R4)”
The paper clearly identifies the snapshot as 'release 4' (or R4), which is a version token.
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
“https://bitbucket.org/NIAGADS/vcpa‐pipeline/src/master/”
A machine-resolvable code repository URL is given for the study's own code.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“U54AG052427”
The paper provides specific grant numbers, such as U54AG052427, for the funding.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“FASTQs were first mapped/remapped to hg38 reference genome using BWA‐mem (v0.7.15)”
The paper names specific software with version tokens (BWA-mem v0.7.15) used to produce the data.
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“We provide sequencing methods, quality data metrics, variant metrics, phenotypes, and readmes along with these data files.”
The paper states that READMEs (documentation objects) are included with the deposited data. [majority verdict 'yes' (4/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0.124
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 25 citers.
University of Pennsylvania
Grant: U24‐AG041689
National Institutes of Health
Grant: UF1AG047133
National Institutes of Health
Grant: U01 AG006781
National Institutes of Health
Grant: U19 AG066567
Mayo Clinic
Grant: R01 AG032990
Mayo Clinic
Grant: U01 AG046139
Mayo Clinic
Grant: R01 NS080820
Mayo Clinic
Grant: RF1 AG051504
Mayo Clinic
Grant: P50 AG016574
University of Miami
Grant: R01 AG027944
University of Miami
Grant: R01 AG028786
University of Miami
Grant: R01 AG019085
University of Miami
Grant: IIRG09133827
University of Miami
Grant: A2011048
Case Western Reserve University
Grant: R01 AG019757
Case Western Reserve University
Grant: R01 AG021547
Case Western Reserve University
Grant: P01 NS026630
Alzheimer's Disease Neuroimaging Initiative
Grant: U19AG024904)
Baylor College of Medicine
Grant: U54 HG003273
Uniformed Services University of the Health Sciences
Grant: U01AG057659
University of Southern California
Grant: U01 AG024904
Arizona Department of Health Services
Grant: U01 AG046152
Arizona Department of Health Services
Grant: R01 AG043617
Arizona Department of Health Services
Grant: R01 AG042210
Arizona Department of Health Services
Grant: R01 AG036042
Arizona Department of Health Services
Grant: R01 AG036836
Arizona Department of Health Services
Grant: R01 AG18023
Arizona Department of Health Services
Grant: RC2 AG036547
Arizona Department of Health Services
Grant: U01 ES017155
Arizona Department of Health Services
Grant: KL2 RR024151
Arizona Department of Health Services
Grant: K25 AG041906‐01
Arizona Department of Health Services
Grant: R01 AG30146
Arizona Department of Health Services
Grant: P30 AG10161
Arizona Department of Health Services
Grant: R01 AG17917
Arizona Department of Health Services
Grant: R01 AG15819
Arizona Department of Health Services
Grant: K08 AG034290
Arizona Department of Health Services
Grant: R01 AG11101
Arizona Department of Health Services
Grant: R01AG046170
Arizona Department of Health Services
Grant: RF1AG054014
Arizona Department of Health Services
Grant: RF1AG057440
Arizona Department of Health Services
Grant: R01AG057907
Arizona Department of Health Services
Grant: HHSN271201300031C
Arizona Department of Health Services
Grant: AG030653
Arizona Department of Health Services
Grant: AG041718
Arizona Department of Health Services
Grant: AG064877
Arizona Department of Health Services
Grant: P30‐AG066468
Arizona Department of Health Services
Grant: U01 AG016976
Arizona Department of Health Services
Grant: P30 AG013846
Arizona Department of Health Services
Grant: P50 AG008702
Arizona Department of Health Services
Grant: P50 AG025688
Arizona Department of Health Services
Grant: P30 AG010133
Arizona Department of Health Services
Grant: P50 AG005146
Arizona Department of Health Services
Grant: P50 AG005134
Arizona Department of Health Services
Grant: P30 AG013854
Arizona Department of Health Services
Grant: P30 AG008017
Arizona Department of Health Services
Grant: P30 AG010161
Arizona Department of Health Services
Grant: P30 AG010129
Arizona Department of Health Services
Grant: P50 AG016573
Arizona Department of Health Services
Grant: P30 AG010124
Arizona Department of Health Services
Grant: P50 AG005142
Arizona Department of Health Services
Grant: P30 AG012300
Arizona Department of Health Services
Grant: P50 AG005136
Arizona Department of Health Services
Grant: P30 AG028377
Arizona Department of Health Services
Grant: P50 AG008671
Arizona Department of Health Services
Grant: U24 AG21886
Arizona Department of Health Services
Grant: U01AG032984
Arizona Department of Health Services
Grant: RC2AG036528
Arizona Department of Health Services
Grant: U54NS100693
Arizona Department of Health Services
Grant: U54AG052427
Tau Consortium
Grant: P01AG017586
Alzheimer Disease Among African Americans Study
Grant: 2R01AG048927
NHLBI NIH HHS
Grant: HHSN268201100005G
NHLBI NIH HHS
Grant: N01 HC085080
NHLBI NIH HHS
Grant: N01 HC085083
NHLBI NIH HHS
Grant: N01 HC085086
Mayo Parkinson's Disease
Grant: NS039764
NIA NIH HHS
Grant: P01 AG003991
Darrell K Royal Texas Alzheimer's Initiative
Grant: P01AG03991
NIA NIH HHS
Grant: P30 AG066519
NIA NIH HHS
Grant: P30 AG072947
NIA NIH HHS
Grant: P30 AG072958
NIA NIH HHS
Grant: P50 AG005681
NIA NIH HHS
Grant: R01 AG018023
NIA NIH HHS
Grant: R01 AG021136
NIA NIH HHS
Grant: R01 AG041797
NIA NIH HHS
Grant: R01 AG048927
NIA NIH HHS
Grant: R01 AG051125
NINDS NIH HHS
Grant: R01 NS069719
Hillblom Aging Network
Grant: R01AG048234
Darrell K Royal Texas Alzheimer's Initiative
Grant: R01AG057777
Alzheimer's Therapeutic Researc Institute
Grant: R01AG064877
Alzheimer's Therapeutic Researc Institute
Grant: R56AG051876
NHGRI NIH HHS
Grant: RC2 HG005605
NIA NIH HHS
Grant: RF1 AG054080
NIA NIH HHS
Grant: U01 AG049505
NIA NIH HHS
Grant: U01 AG052410
NIA NIH HHS
Grant: U19 AG024904
NHGRI NIH HHS
Grant: U54 HG003067
Dutch Research Council (NWO)
Grant: 175.010.200
Hillblom Aging Network
Grant: 2014-A-004-NET
CubanAmerican Alzheimer's Disease Initiative
Grant: 3U01AG052410
European Community's Seventh Framework
Grant: HEALTH-F4- 2007-201413
NHLBI NIH HHS
Grant: HHSN268200800007C
NHLBI NIH HHS
Grant: HHSN268201100007I
NIA NIH HHS
Grant: K23 AG030944
NHLBI NIH HHS
Grant: N01 HC085079
NIA NIH HHS
Grant: P01 AG026276
NIA NIH HHS
Grant: P20 AG068024
NIA NIH HHS
Grant: P30 AG028383
NIA NIH HHS
Grant: P30 AG066468
NIA NIH HHS
Grant: P30 AG066509
NINDS NIH HHS
Grant: P50 NS072187
NIA NIH HHS
Grant: R01 AG009029
NIA NIH HHS
Grant: R01 AG020098
NIA NIH HHS
Grant: R01 AG030146
NIA NIH HHS
Grant: R01 AG049607
NIA NIH HHS
Grant: R01 AG058501
NIA NIH HHS
Grant: R01 AG059716
NINDS NIH HHS
Grant: R01 NS029993
Darrell K Royal Texas Alzheimer's Initiative
Grant: R01AG044546
Longevity Genes Project
Grant: R01AG057909
Longevity Genes Project
Grant: R01AG061155
The Longitudinal Aging Study in India
Grant: R01AG064614
Northern Manhattan Study
Grant: R01NS29993
NIA NIH HHS
Grant: R37 AG015473
NHLBI NIH HHS
Grant: RC2 HL102419
NIA NIH HHS
Grant: RF1 AG054047
Estudio Familiar de Influencia Genetica en Alzheimer
Grant: RF1AG015473
Case Western Reserve University Rapid Decline
Grant: RF1AG058267
Alzheimer's Therapeutic Researc Institute
Grant: RF1AG058501
NIA NIH HHS
Grant: U01 AG052409
NIA NIH HHS
Grant: U01 AG058589
NIA NIH HHS
Grant: U01 AG068057
NHLBI NIH HHS
Grant: U01 HL096814
NIA NIH HHS
Grant: U24 AG021886
University of Pennsylvania
Grant: U24-AG041689
NHGRI NIH HHS
Grant: U54 HG003079
Ibadan Study of Aging
Grant: 5R01AG009956
NHLBI NIH HHS
Grant: HHSN268201100005C
NHLBI NIH HHS
Grant: HHSN268201100009I
NHLBI NIH HHS
Grant: HHSN268201200036C
Arizona Department of Health Services
Grant: K25 AG041906-01
NIA NIH HHS
Grant: P30 AG062429
NIA NIH HHS
Grant: P30 AG062715
NIA NIH HHS
Grant: P30 AG066462
NIA NIH HHS
Grant: P30 AG066508
NIA NIH HHS
Grant: P30 AG066511
NIA NIH HHS
Grant: P30 AG072946
NIA NIH HHS
Grant: P30 AG072972
NIA NIH HHS
Grant: R01 AG011101
NIA NIH HHS
Grant: R01 AG015819
NIA NIH HHS
Grant: R01 AG019771
Darrell K Royal Texas Alzheimer's Initiative
Grant: R01 AG025711
NIA NIH HHS
Grant: R01 AG033040
NIA NIH HHS
Grant: R01 AG054047
NIA NIH HHS
Grant: R01 AG063689
Wisconsin Registry for Alzheimer's Prevention
Grant: R01AG027161
Longevity Genes Project
Grant: R01AG046949
NIA NIH HHS
Grant: RF1 AG054023
NIA NIH HHS
Grant: RF1 AG058066
Peru Alzheimer's Disease Initiative
Grant: RF1AG054074
NIA NIH HHS
Grant: U01 AG006786
NHLBI NIH HHS
Grant: U01 HL130114
NINDS NIH HHS
Grant: U01 NS041588
Darrell K Royal Texas Alzheimer's Initiative
Grant: U01AG058922
The Longitudinal Aging Study in India
Grant: U01AG065958
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site
Grant: U24AG041689
Morris K. Udall Parkinson's Disease Research Center of Excellence
Grant: #NS072187
European Research Council
Grant: 340755
10/66 ten years on – monitoring and improving health expectancy by targeting frailty among older people in middle income countries
Alzheimer's Therapeutic Researc Institute
Grant: 5R37AG015473
NHLBI NIH HHS
Grant: HHSN268201100006C
NHLBI NIH HHS
Grant: HHSN268201100008I
NHLBI NIH HHS
Grant: HHSN268201100012C
NHLBI NIH HHS
Grant: HHSN268201500001I
NIA NIH HHS
Grant: P30 AG062421
NIA NIH HHS
Grant: P30 AG066444
NIA NIH HHS
Grant: P30 AG066512
NIA NIH HHS
Grant: P30 AG066546
NIA NIH HHS
Grant: P30 AG072975
Alzheimer's Disease Research Centers
Grant: P30 AG079280
Arizona Department of Health Services
Grant: P30-AG066468
NINDS NIH HHS
Grant: P50 NS071674
Darrell K Royal Texas Alzheimer's Initiative
Grant: R01 AG017216
NIA NIH HHS
Grant: R01 AG032289
NIA NIH HHS
Grant: R01 AG044829
NIA NIH HHS
Grant: R01 AG079280
NHLBI NIH HHS
Grant: R01 HL070825
NHLBI NIH HHS
Grant: R01 HL105756
Cache County Study
Grant: R01AG11380
NIA NIH HHS
Grant: R56 AG064877
NIA NIH HHS
Grant: U01 AG049508
NIA NIH HHS
Grant: U01 AG058654
NIA NIH HHS
Grant: U01 AG062602
NHLBI NIH HHS
Grant: U01 HL096899
NHLBI NIH HHS
Grant: U01 HL096917
NIA NIH HHS
Grant: U24 AG074855
NHLBI NIH HHS
Grant: HHSN268201100007C
NHLBI NIH HHS
Grant: HHSN268201100008C
NHLBI NIH HHS
Grant: HHSN268201100011I
NIA NIH HHS
Grant: P20 AG068082
NIA NIH HHS
Grant: P30 AG038072
NIA NIH HHS
Grant: P30 AG062422
NIA NIH HHS
Grant: P30 AG066515
NIA NIH HHS
Grant: P30 AG066518
Genetic Differences
Grant: R01 AG007584
NIA NIH HHS
Grant: R01 AG017917
NIA NIH HHS
Grant: R01 AG030653
NIA NIH HHS
Grant: R01 AG031272
NIA NIH HHS
Grant: R01 AG041718
NIA NIH HHS
Grant: R01 AG042188
NIA NIH HHS
Grant: R01 AG054076
NIA NIH HHS
Grant: R01 AG058066
Religious Orders Study
Grant: R01 AG42210
NIA NIH HHS
Grant: RF1 AG057519
NIA NIH HHS
Grant: U01 AG049506
NIA NIH HHS
Grant: U01 AG062943
NIA NIH HHS
Grant: U24 AG072122
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site
Grant: W81XWH-12-2-0012
Multi-Institutional Research in Alzheimer's Genetic Epidemiology
Grant: 2R01AG09029
NHLBI NIH HHS
Grant: HHSN268201100009C
NHLBI NIH HHS
Grant: N01 HC085081
Case Western Reserve University Rapid Decline
Grant: NU38CK000480
NIA NIH HHS
Grant: P20 AG068053
NIA NIH HHS
Grant: P20 AG068077
NIA NIH HHS
Grant: P30 AG019610
NIA NIH HHS
Grant: P30 AG062677
NIA NIH HHS
Grant: P30 AG066506
NIA NIH HHS
Grant: P30 AG066507
NIA NIH HHS
Grant: P30 AG066514
NIA NIH HHS
Grant: P30 AG072977
MND Victoria
Grant: P30 AG19610
Religious Orders Study
Grant: P30 AG72975
NIA NIH HHS
Grant: P50 AG025711
Case Western Reserve University Brain Bank
Grant: P50AG008012
Darrell K Royal Texas Alzheimer's Initiative
Grant: R01 AG003949
NIA NIH HHS
Grant: R01 AG015928
NIA NIH HHS
Grant: R01 AG025259
NIA NIH HHS
Grant: R01 AG033193
NIA NIH HHS
Grant: RF1 AG053303
NIA NIH HHS
Grant: RF1 AG054052
NIA NIH HHS
Grant: U01 AG046170
NIA NIH HHS
Grant: U01 AG052411
NHLBI NIH HHS
Grant: U01 HL096812
NHLBI NIH HHS
Grant: U01 HL096902
Alzheimer's Disease Centers
Grant: U24AG056270
Mayo Parkinson's Disease
Grant: 5RC2HG005605
NHLBI NIH HHS
Grant: HHSN268201100010C
NHLBI NIH HHS
Grant: HHSN268201100011C
NIA NIH HHS
Grant: K25 AG041906
Mayo Parkinson's Disease
Grant: NS071674
NIA NIH HHS
Grant: P01 AG003949
NIA NIH HHS
Grant: P30 AG066530
NIA NIH HHS
Grant: P30 AG072959
NIA NIH HHS
Grant: P30 AG072973
NIA NIH HHS
Grant: P30 AG072978
Quality of Life and Management of the Living Resources
Grant: QLG2-CT-2002- 01254
NIA NIH HHS
Grant: R01 AG023629
NIA NIH HHS
Grant: R01 AG060747
NIA NIH HHS
Grant: R01 AG074328
NINDS NIH HHS
Grant: R01 NS017950
Mexican Health and Aging Study
Grant: R01AG018016
Cache County Study
Grant: R01AG21136
NIA NIH HHS
Grant: U01 AG049507
NINDS NIH HHS
Grant: UG3 NS104095
Dutch Research Council (NWO)
Grant: 047.017.043
Dissecting genetic complexity of Alzheimer's disease and cognitive function
NHLBI NIH HHS
Grant: HHSN268201100005I
NHLBI NIH HHS
Grant: HHSN268201500001C
NHLBI NIH HHS
Grant: N01 HC055222
NHLBI NIH HHS
Grant: N01 HC085082
NIA NIH HHS
Grant: P01 AG017216
NIA NIH HHS
Grant: P30 AG072931
NIA NIH HHS
Grant: P30 AG072976
NIA NIH HHS
Grant: P30 AG072979
NIA NIH HHS
Grant: P50 AG005131
Darrell K Royal Texas Alzheimer's Initiative
Grant: P50 AG05681
NINDS NIH HHS
Grant: P50 NS039764
NIA NIH HHS
Grant: R01 AG009956
NIA NIH HHS
Grant: R01 AG011380
Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study
Grant: R01 AG09029
NIA NIH HHS
Grant: RC4 AG039085
Darrell K Royal Texas Alzheimer's Initiative
Grant: U01 AG006576
NIA NIH HHS
Grant: U01 AG058635
NHLBI NIH HHS
Grant: U01 HL080295
NINDS NIH HHS
Grant: U24 NS072026
National Institutes of Health
Grant: 5U54AG052427-05
Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD)
National Institutes of Health
Grant: 5P01NS026630-07
GENETIC LINKAGE STUDIES IN NEUROGENETIC DISORDERS
National Institutes of Health
Grant: 2R01AG033040-06
MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults
National Institutes of Health
Grant: 3R37AG015473-09S1
Genetic Epidemiology of Alzheimers Disease in Hispanics
National Institutes of Health
Grant: 5R01AG041797-04
Epidemiology of Familial Late-Onset Alzheimer's Disease
National Institutes of Health
Grant: 3RF1AG051504-01S1
Integrative translational discovery of vascular risk factors in aging and dementia
National Institutes of Health
Grant: 3R01NS080820-02S1
Gene discovery in PSP by transcriptome, neuropathology and sequence analysis
National Institutes of Health
Grant: 5U01AG052411-03
Identification and characterization of AD risk networks using multi-dimensional "omics" data
National Institutes of Health
Grant: 5U24NS072026-03
National Brain and Tissue Resource for Parkinson's Disease and Related Disorders
National Institutes of Health
Grant: N01HC085086-019
CENTRAL BLOOD ANALYSIS LABORATORY FOR CHS
National Institutes of Health
Grant: 5R01AG018023-10
Plasma AB as a Surrogate Genetic Marker for LOAD
National Institutes of Health
Grant: 5R01AG023629-03
Exceptional aging: 12 year trajectories to function
National Institutes of Health
Grant: 5R01AG021136-02
Progression of Dementia: A Population
National Institutes of Health
Grant: 1P30AG010161-01
SHORT-TERM STABILITY OF CLINICAL TESTS
National Institutes of Health
Grant: 1P30AG066512-01
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG066506-01
1Florida Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG015819-07
Risk Factors, Pathology, and Clinical Expressions of AD
National Institutes of Health
Grant: 5R01AG009029-03
GENETIC EPIDEMIOLOGICAL STUDIES OF ALZHEIMERS DISEASE
National Institutes of Health
Grant: 1P30AG028377-01
DATA MANAGEMENT AND STATISTICS CORE
National Institutes of Health
Grant: 5U01HL096812-08
ARIC Neurocognitive Study (ARIC-NCS) 1 of 5
National Institutes of Health
Grant: 3P30AG012300-06S1
ROLE FOR FIBROBLAST GROWTH FACTOR IN ALZHEIMERS DISEASE
National Institutes of Health
Grant: 3U01AG046170-01S1
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative
National Institutes of Health
Grant: N01HC085082-024
CORONARY HEART DISEASE AND STROKE
National Institutes of Health
Grant: 5U24AG041689-07
THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE
National Institutes of Health
Grant: 1R01AG027161-01A2
Wisconsin Registry for Alzheimer Prevention: Biomarkers of Preclinical AD
National Institutes of Health
Grant: 3U24AG074855-03S1
MVP Data Integration into the ADSP Phenotype Harmonization Consortium
National Institutes of Health
Grant: 2P50AG008671-11
CORE--CLINICAL
National Institutes of Health
Grant: 2P30AG019610-11
Education and Information Transfer Core
National Institutes of Health
Grant: 3P50AG005134-04S3
ALZHEIMERS DISEASE RESEARCH CENTER
National Institutes of Health
Grant: 5P30AG072979-02
Penn Alzheimer's Disease Research Center (ADRC)
National Institutes of Health
Grant: 1RF1AG054014-01
Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis
National Institutes of Health
Grant: 5U01AG049505-02
CHARGE: Identifying Risk & Protective SNV for AD in ADSP Case-control Sample
National Institutes of Health
Grant: 5R01AG060747-03
The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort
National Institutes of Health
Grant: 5P30AG062677-02
Mayo Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P50AG008702-11A1S1
GENES, AGING, LEARNING AND DEMENTIA
National Institutes of Health
Grant: 5P30AG072975-02
Rush Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3R01AG057777-02S1
MENDELIAN RANDOMIZATION FOR UNBIAS BIOMARKER DISCOVERY FOR AD AND OTHER COMPLEX TRAITS
National Institutes of Health
Grant: 5UG3NS104095-03
Impact of coding and non-coding variation in progressive supranuclear palsy
National Institutes of Health
Grant: 5P20AG068082-02
Vanderbilt Alzheimer's Disease Research Center
Austrian Science Fund (FWF)
Grant: I 904
Mechanisms of Small Vessel Related Brain Damage and Cognitive Impairment
National Institutes of Health
Grant: 1UF1AG047133-01
Consortium for Alzheimers Sequence Analysis (CASA)
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 5P30AG066518-03
Oregon Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3U01AG052410-04S1
Replication and Extension of ADSP Discoveries in African-Americans
National Institutes of Health
Grant: 1RF1AG057440-01
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease
National Institutes of Health
Grant: N01HC085080-018
CORONARY HEART DISEASE &STROKE IN THE ELDERLY
National Institutes of Health
Grant: 5P01AG026276-07
Antecedent Neuroimaging Biomarkers
National Institutes of Health
Grant: 2P50AG025688-11
A Proteogenomic Approach to Understanding AD GWAS Results
National Institutes of Health
Grant: 5R01AG059716-03
Genetic Drivers of Resilience to Alzheimer's Disease
National Institutes of Health
Grant: 1R01AG031272-01A1
Lifespan Stressors and Alzheimer's Disease: The Cache County Study
National Institutes of Health
Grant: 3P30AG066514-01S1
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3R01AG054076-02S1
Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham Cohorts
National Institutes of Health
Grant: 1RF1AG057519-01
Genomic and Biological Studies of APOE ε2 in Alzheimer Disease
National Institutes of Health
Grant: 1RF1AG058267-01
Characterization of Rapidly Progressive Alzheimer's Disease
National Institutes of Health
Grant: 5U24AG021886-18
National Cell Repository for Alzheimer's Disease (NCRAD)
National Institutes of Health
Grant: 5K25AG041906-02
Integrative analysis of genomic and epigenomic architecture in cognitive decline
National Institutes of Health
Grant: 5R01AG019085-08
Genetic Studies of Dementia in the Amish
National Institutes of Health
Grant: 5P50AG008012-13
CORE--CLINICAL
National Institutes of Health
Grant: 5R01AG019757-03
An Integrated Genomic Approach to Alzheimer Disease
National Institutes of Health
Grant: N01HC025195-005
THE FRAMINGHAM HEART STUDY-268025195
National Institutes of Health
Grant: N01HC085083-021
CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84
National Institutes of Health
Grant: 5P01AG003991-38
Healthy Aging and Senile Dementia
National Institutes of Health
Grant: 5R01AG048234-05
Effects of chronic inflammation on brain structure and function
National Institutes of Health
Grant: 3P30AG013846-23S1
Boston University Alzheimer's Disease Center
National Institutes of Health
Grant: 5R01AG057909-02
Resilience to Alzheimer's disease in humans with exceptional longevity
National Institutes of Health
Grant: 3RF1AG053303-01S1
USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITS
National Institutes of Health
Grant: 5U54NS100693-02
Identifying genes and Pathways that impact Tau Toxicity in FTD
National Institutes of Health
Grant: 1RF1AG054052-01
Epidemiology of Alzheimer’s disease resilience and risk pedigrees
National Institutes of Health
Grant: N01HC085079-023
CORONARY HEART DISEASE AND STROKE
National Institutes of Health
Grant: 5P50AG005136-21
ALZHEIMERS DISEASE RESEARCH CENTER
National Institutes of Health
Grant: 5RC2AG036528-02
Genome Wide associate analysis of Alzheimer's Disease
National Institutes of Health
Grant: 2U01HL096917-05
ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5
National Institutes of Health
Grant: 5P50AG005146-20
ALZHEIMERS DISEASE AND ANIMAL MODELS
National Institutes of Health
Grant: 3P30AG010129-28S1
UC Davis Alzheimer's Core Center
National Institutes of Health
Grant: 3P30AG066509-03S1
Biological heterogeneity in ADRD
National Institutes of Health
Grant: 5P50AG005131-25
CORE--CLINICAL
National Institutes of Health
Grant: 5P30AG062422-03
New Approaches to Dementia Heterogeneity
National Institutes of Health
Grant: 3U01NS041588-10S1
Etiology of Geographic and Racial Differences in Stroke
National Institutes of Health
Grant: 5P30AG062715-02
Wisconsin Alzheimer's Disease Research center
National Institutes of Health
Grant: 5P30AG013854-05
CORE--CLINICAL
National Institutes of Health
Grant: 3RF1AG054074-01S1
Genomic Characterization of Alzheimer's Disease Risk in the Puerto Rican Population
National Institutes of Health
Grant: 3R01AG011101-03S1
RISK FACTORS FOR INCIDENT AD IN A BIRACIAL COMMUNITY
National Institutes of Health
Grant: 5R01AG054047-02
Genomic and Metabolomic Data Integration in a Longitudinal Cohort at Risk for Alzheimer's Disease
National Institutes of Health
Grant: 3P30AG066462-01S1
Alzheimer's Disease Research Center Determinants of health seeking behaviors during COVID-19 in persons with MCI/ADRD and their caregivers
National Institutes of Health
Grant: 2R01AG007584-09A2
GENETIC DIFFERENCES IN ALZHEIMERS CASES AND CONTROLS
National Institutes of Health
Grant: 1P30AG072972-01
UC Davis Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG057907-03
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease
National Institutes of Health
Grant: 5P50AG016573-09
CORE--NEUROPATHOLOGY CORE
National Institutes of Health
Grant: 5U01AG062943-03
Additional Sequencing Cohorts for the Alzheimer's Disease Sequencing Project
National Institutes of Health
Grant: 2P50AG005142-31
Metabolic Factors in AD
National Institutes of Health
Grant: 5R01HL070825-03
The ARIC and Neurocognitive Longitudinal Study
National Institutes of Health
Grant: 3U54HG003079-03S1
Large Scale Genome Sequencing
National Institutes of Health
Grant: 5U01AG006781-29
Alzheimer's Disease Patient Registry (ADPR/ACT)
National Institutes of Health
Grant: 3RF1AG054023-01S1
Genetic Epidemiology of Cerebrovascular Factors in Alzheimer's Disease
National Institutes of Health
Grant: 5U01AG046139-03
A system approach to targeting innate immunity in AD
National Institutes of Health
Grant: 5R01AG044546-03
IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMER'S DISEASE
National Institutes of Health
Grant: 1U19AG066567-01A1
Adult Changes in Thought (ACT) Research Program
National Institutes of Health
Grant: 5P50NS072187-04
Identification of novel Parkinsonian genes by wholegenome
National Institutes of Health
Grant: 1RC2HL102419-01
Building on GWAS for NHLBI-disease: the CHARGE consortium
National Institutes of Health
Grant: 3P30AG066530-04S1
Alzheimer Disease Research Center
National Institutes of Health
Grant: 2R01AG018016-06A1
The Mexican Health and Aging Study - II
National Institutes of Health
Grant: 1U01AG068057-01
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks
National Institutes of Health
Grant: 5R01AG021547-03
Alzheimers Disease and Gene Discovery on Chromosome 9
National Institutes of Health
Grant: 3R01AG064877-02S1
Genetic Architecture of Alzheimer’s disease Proteinopathies
National Institutes of Health
Grant: 1RC2AG036547-01
Cognitive Decline and Dementia: Life Experiences and the Brain Histone Epigenome
National Institutes of Health
Grant: 1P30AG066546-01A1
South Texas Alzheimer's Disease Center
National Institutes of Health
Grant: 5U01AG058589-02
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches
National Institutes of Health
Grant: 3P50AG016574-06S1
Mayo Alzheimers Disease Research Center
National Institutes of Health
Grant: 5P20AG068024-02
UAB Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG066508-03
Yale Alzheimer Disease Research Center
National Institutes of Health
Grant: 5P30AG072947-02
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG036836-03
Exploring the Role of the Brain Transcriptome in Cognitive Decline
National Institutes of Health
Grant: 5P30AG028383-07
Clinical Core
National Institutes of Health
Grant: 3P30AG010124-28S1
Alzheimer's Disease Core Center - Neuroimaging Core I
National Institutes of Health
Grant: 1RC4AG039085-01
Building Research Infrastructure & Network in Chicago Chinatown
National Institutes of Health
Grant: 5P50AG005681-19
Role of LRP &its ligand tPA in LTP &aging
National Institutes of Health
Grant: 5U01AG049506-02
Sequence-based Discovery of AD Risk & Protective Alleles
National Institutes of Health
Grant: 5P30AG066515-03
Stanford Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5U01AG062602-02
Genetic Studies of Alzheimer Disease in Koreans
National Institutes of Health
Grant: 5R01AG020098-05
Alzheimers Disease in Mild Cognitive Impairment
National Institutes of Health
Grant: 1R01AG043617-01
Altered monocyte function in relation to the CD33 Alzheimers disease locus
National Institutes of Health
Grant: 5R01AG036042-05
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences
National Institutes of Health
Grant: 3P30AG066519-01S1
The Alzheimer's Disease Research Center at the University of California, Irvine
National Institutes of Health
Grant: 3RF1AG054080-01S1
Genetic Epidemiology of Early-Onset Alzheimers disease in Caribbean Hispanics and non-Hispanic Whites
National Institutes of Health
Grant: 5P30AG062429-03
UCSD Alzheimer's Disease Research Centers P30
National Institutes of Health
Grant: 5U01HL096814-02
ARIC Neurocognitive Study (ARIC-NCS)
National Institutes of Health
Grant: 1P30AG072958-01
Duke/UNC Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG061155-05
Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease
National Institutes of Health
Grant: 1R01AG015928-01
COGNITIVE TESTS, APOE, BRAIN MRI AND RISKS OF DEMENTIA
National Institutes of Health
Grant: 1K08AG034290-01
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila
National Institutes of Health
Grant: 3R01AG048927-07S1
Alzheimer Disease Genetic Architecture in African Americans
National Institutes of Health
Grant: 5P30AG072977-02
NORTHWESTERN Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5U24AG072122-03
National Alzheimer's Coordinating Center
National Institutes of Health
Grant: 5R01NS017950-40
Precursors of Stroke Incidence and Prognosis
National Institutes of Health
Grant: 5U01AG058635-03
Genomic approach to identification of microglial networks involved in Alzheimer disease risk
National Institutes of Health
Grant: 4R01AG042210-05
Epidemiologic Study of TDP-43 Pathology in Aging and Dementia
National Institutes of Health
Grant: 5U01AG016976-03
ALZHEIMERS DISEASE DATA COORDINATING CENTER
National Institutes of Health
Grant: 5R01NS029993-14
Stroke Incidence and Risk Factors in a Tri-Ethnic Region
National Institutes of Health
Grant: N01HC055222-001
CHS-Transition Phase -268055222
National Institutes of Health
Grant: 1U01HL080295-01
CHS Events Follow-up Study
National Institutes of Health
Grant: N01HC085081-016
CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84
National Institutes of Health
Grant: 1R01AG064614-01
Dissecting the Genomic Etiology of non-Mendelian Early-Onset Alzheimer Disease and Related Phenotypes
National Institutes of Health
Grant: 5P30AG010133-08
CORE-- EDUCATION AND INFORMATION TRANSFER
National Institutes of Health
Grant: 5R01AG009956-09
INDIANAPOLIS/IBADAN DEMENTIA PROJECT
National Institutes of Health
Grant: 5U01AG049508-03
Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD)
National Institutes of Health
Grant: 1R01AG046949-01
LGP/Longenity
National Institutes of Health
Grant: 1KL2RR024151-01
CTSA: K12 COMPONENT
Austrian Science Fund (FWF)
Grant: P 20545
Genetics of Cerebral Small Vessel Disease
National Institutes of Health
Grant: 5P30AG062421-03
Massachusetts Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3R01AG030653-06A1S1
Search for the Alzheimers Genes
Austrian Science Fund (FWF)
Grant: P 13180
MRI white matter abnormalities in the elderly: Genetic risk factors, rate of progression and neuropsychologic consequences
National Institutes of Health
Grant: 3U54HG003273-04S1
Genomes and Genetics at the BCM-HGSC
National Institutes of Health
Grant: 1R56AG051876-01A1
Genetic Modifiers of Alzheimer Disease in PSEN1 Mutation Carriers in Puerto Rico
National Institutes of Health
Grant: 1P30AG066444-01
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 2R01AG022018-12
Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease
National Institutes of Health
Grant: 5U24AG056270-05
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)
National Institutes of Health
Grant: 5U01AG032984-15
Alzheimer's Disease Genetics Consortium
National Institutes of Health
Grant: 1U01AG058654-01A1
The Alzheimer Disease Sequence Analysis Collaborative
National Institutes of Health
Grant: 5U01AG058922-05
The Familial Alzheimer Sequencing (FASe) Project
National Institutes of Health
Grant: 3U19AG024904-18S3
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
National Institutes of Health
Grant: 5R01AG041718-03
Deep Resequencing of Candidate Gene Regions in Late-onset Alzheimer's Disease
National Institutes of Health
Grant: 5U01HL096902-06
ARIC Neurocognitive Study (ARIC-NCS)
National Institutes of Health
Grant: 5P30AG066507-03
Johns Hopkins Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P20AG068053-03
Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC)
National Institutes of Health
Grant: 1RC2HG005605-01
Statistical Methods for Next-Gen Sequencing in Disease Association Studies
National Institutes of Health
Grant: 5R01AG032990-02
Genome wide association study of gene expression levels in Alzheimer's disease
National Institutes of Health
Grant: 1R01AG033193-01
Collaborative GWAS of Dementia, AD and related MRI and Cognitive Endophenotypes
National Institutes of Health
Grant: 3RF1AG058066-01S1
Protective Genetic Variants for Alzheimer Disease in the Amish
National Institutes of Health
Grant: 1RF1AG058501-01
GENETIC MODIFIERS OF CEREBROSPINAL FLUID TREM2 IN ALZHEIMER'S DISEASE
National Institutes of Health
Grant: 5P30AG072976-02
Indiana Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG072931-01
Michigan Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1R01AG027944-01A2
Genomic Convergence in Alzheimer Disease
National Institutes of Health
Grant: 2R01HL105756-07
CHARGE consortium: gene discovery for CVD and aging phenotypes
National Institutes of Health
Grant: 3P30AG066468-01S1
Comparison of tau-PET tracers: Progress towards a universal measure
European Commission
Grant: 201413
European Network for Genetic and Genomic Epidemiology
National Institutes of Health
Grant: 3P30AG066511-03S2
Piloting a web-based neuropathology image resource for the ADRC community
National Institutes of Health
Grant: 2R01AG019771-06
Memory Circuitry in MCI and Early Alzheimers Disease
National Institutes of Health
Grant: 5R01AG011380-02
EPIDEMIOLOGY OF ALZHEIMERS DEMENTIA IN CACHE COUNTY UT
National Institutes of Health
Grant: 5P30AG038072-14
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging
National Institutes of Health
Grant: 5P01AG017586-18
Frontotemporal Dementias: Genotypes and Phenotypes
National Institutes of Health
Grant: 5R01AG042188-03
Epigenetic Profiling in Healthy Aging and Exceptional Longevity
National Institutes of Health
Grant: 3K23AG030944-02S1
Consequences of Self-Neglect in a Biracial Population of Older People
National Institutes of Health
Grant: 5R01AG051125-07
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Surveys in India (LASI)
National Institutes of Health
Grant: 7U01AG046152-05
Pathway discovery, validation and compound identification for Alzheimer's disease
National Institutes of Health
Grant: 5R01AG049607-05
Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults
National Institutes of Health
Grant: 5R01AG025259-04
Multi-ethnic genome-wide Alzheimer association study
National Institutes of Health
Grant: 1P30AG072978-01
Boston University Alzheimer's Disease Research Center
National Institutes of Health
Grant: 2R01AG030146-06A1
Genetic Epidemiology of Cognitive Decline in an Aging Population Sample
National Institutes of Health
Grant: 2U01AG006786-04
ALZHEIMERS DISEASE PATIENT REGISTRY
National Institutes of Health
Grant: 3P30AG072946-02S1
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
National Institutes of Health
Grant: 5R01AG032289-02
Mechanisms of Executive Decline in Normal Aging
National Institutes of Health
Grant: 1R01AG028786-01A1
Genetic Epidemiology of Alzheimers Disease in African Americans
Wellcome Trust
Grant: 066133
The epidemiology of dementia and Alzheimer's disease in admixed populations in Brazil and Cuba.
National Institutes of Health
Grant: 5U01AG049507-03
Sequence-based Discovery of AD Risk & Protective Alleles
National Institutes of Health
Grant: 2P30AG008017-21
EDUCATION AND INFORMATION CORE
National Institutes of Health
Grant: 3U01HL130114-03S1
CHS research resources for the cardiovascular health of older adults
National Institutes of Health
Grant: 5P30AG072959-02
Cleveland Alzheimers Disease Research Center
National Institutes of Health
Grant: 5U01HL096899-02
ARIC Neurocognitive Study (ARIC-NCS)
National Institutes of Health
Grant: 1U01AG052409-01
ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems
National Institutes of Health
Grant: 6R01AG044829-03
Role of exceptional longevity genotypes in protection against frailty in aging
National Institutes of Health
Grant: 3U54HG003067-07S1
Large Scale Sequencing and Analysis of Genomes
National Institutes of Health
Grant: 1R01NS069719-01
Next Generation gene discovery in neurogenetics
National Institutes of Health
Grant: 3U01AG057659-02S1
Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS)
National Institutes of Health
Grant: 5P20AG068077-03
New Mexico Alzheimer's Disease Research Center
National Institutes of Health
Grant: 1P30AG072973-01
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
National Institutes of Health
Grant: 1U01ES017155-01
Production sequencing of reference human epigenomes
Alzheimer's Association "Identification of Rare Variants in Alzheimer Disease"
Arizona Alzheimer's Disease Core Center
Avid and Cogstate
Biogen
Eisai Inc.
Erasmus Medical Center
Fujirebio
H. Lundbeck A/S
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC.
Large Scale Sequencing and Analysis Centers
Medizinische Universität Graz
National Institute of Biomedical Imaging and Bioengineering
Netherlands Organization
Netherlands Organization of Scientific Research NWO Investments
University of Toronto (UT)
Accelerating Medicines Partnership
Araclon Biotech
Austrian National Bank
BRIDGET
Cardiovascular Health Study
Dutch Research Council (NWO)
EU Joint Programme - Neurodegenerative Disease Research
Erasmus Medisch Centrum
Erasmus University
Framingham Heart Study
Fujirebio US
Mayo Clinic Florida
Merck
Meso Scale Diagnostics, LLC
Meso Scale Diagnostics, LLC.
National Human Genome Research Institute
National Institute on Aging
Novartis Pharmaceuticals Corporation
Piramal Imaging
Rotterdam Study
Steiermärkische Krankenanstalten Gesellschaft
Victorian Brain Bank
Alzheimer's Drug Discovery Foundation
Alzheimer's Association
Alzheimer's Therapeutic Research Institute
CIHR
Center for Genome Technology
Cogstate
Department of Internal Medicine
EU Joint Programme – Neurodegenerative Disease Research
Elan Pharmaceuticals, Inc.
GHR Foundation
Genetic and Environmental Risk Factors
Hussman Institute for Human Genomics
Netherlands Genomics Initiative
Netherlands Organization for Scientific Research and the Russian Foundation for Basic Research
Welfare and Sports
Wellcome Trust
Anniversary Fund
Departments of Neurology and Psychiatry at Washington University School of Medicine
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration
Medical University of Graz
NIBIB NIH HHS
National Heart, Lung, and Blood Institute
Netherlands Consortium for Healthy Aging
NeuroRx Research
Northern California Institute for Research and Education
AbbVie
Austrian Research Promotion agency
Austrian Science Fund FWF
Canadian Institutes of Health Research
Health Research and Development
IXICO Ltd.
Medical Research Council
Merck & Co., Inc.
Oesterreichische Nationalbank
Takeda Pharmaceutical Company
Washington University Genome Institute
Atherosclerosis Risk in Communities
Austrian Science Fond
Eli Lilly and Company
Erasmus Rucphen Family Study
GE Healthcare
Hussman Institute for Human Genomics Brain Bank
Lumosity
Ministry of Education
National Institute on Aging Alzheimer's Disease Data Storage Site
Neurotrack Technologies
Parkinson's Victoria
Prospective Dementia Registry-Austria
Rainwater Charitable Foundation
Rotterdam
U.S. Department of Health and Human Services
Alzheimer's Drug Discovery Foundation
BioClinica, Inc.
CereSpir, Inc.
CurePSP Foundation
Deutsches Zentrum für Neurodegenerative Erkrankungen
European Special Populations Research Network
Genentech, Inc.
German Center for Neurodegenerative Diseases
Lundbeck
Ministry for Health
National Institute of Neurological Disorders and Stroke
National Institutes of Health-National Institute on Aging
Research Institute for Diseases in the Elderly
Alzheimer's Association
Alzheimer's Disease Sequencing Project (ADSP)
American Genome Center
Austrian Stroke Prevention Study
BioClinica
Culture and Science
Erasmus MC
EuroImmun
European Commission
European Research Council
Genentech
Janssen Alzheimer Immunotherapy Research & Development, LLC
Reasons for Geographic and Racial Differences in Stroke
Reta Lila Weston Institute for Neurological Studies
Study Investigators institutions
Victorian Forensic Institute of Medicine
public-private-philanthropic partnership
Alzheimer's Therapeutic Research Institute
Austrian Stroke Prevention Study
Alzheimer's Disease Sequencing Project (ADSP)
Welfare and Sports
Medical Research Council
EuroImmun
American Genome Center
Netherlands Consortium for Healthy Aging
Alzheimer's Association "Identification of Rare Variants in Alzheimer Disease"
Biogen
Johnson & Johnson Pharmaceutical Research & Development LLC.
Framingham Heart Study
Washington University Genome Institute
Ministry of Education
European Special Populations Research Network
Netherlands Organization for Scientific Research
Culture and Science
Victorian Forensic Institute of Medicine
CIHR
CurePSP Foundation
Reta Lila Weston Institute for Neurological Studies
Atherosclerosis Risk in Communities
Erasmus University
European Commission
Alzheimer's Drug Discovery Foundation
Genetic and Environmental Risk Factors
European Research Council
Lumosity
Ministry for Health
Piramal Imaging
Takeda Pharmaceutical Company
Hussman Institute for Human Genomics
Alzheimer's Association
Erasmus Rucphen Family Study
Genentech, Inc.
Study Investigators institutions
Rotterdam
Netherlands Organization for Scientific Research and the Russian Foundation for Basic Research
Anniversary Fund
Araclon Biotech
Medical University of Graz
Novartis Pharmaceuticals Corporation
Meso Scale Diagnostics, LLC.
CereSpir, Inc.
Northern California Institute for Research and Education
Center for Genome Technology
BioClinica, Inc.
Meso Scale Diagnostics, LLC
GE Healthcare
GHR Foundation
Large Scale Sequencing and Analysis Centers
Research Institute for Diseases in the Elderly
Austrian Science Fond
U.S. Department of Health and Human Services
Cardiovascular Health Study
Medical Research Council UK
Parkinson's Victoria
Departments of Neurology and Psychiatry at Washington University School of Medicine
Austrian National Bank
Victorian Brain Bank
Netherlands Organization
AbbVie
Austrian Science Fund
Department of Internal Medicine
Avid and Cogstate
Mayo Clinic Florida
Steiermärkische Krankenanstalten Gesellschaft
Cogstate
Erasmus MC
EU Joint Programme - Neurodegenerative Disease Research
NIBIB NIH HHS
Johnson & Johnson Pharmaceutical Research & Development LLC
Reasons for Geographic and Racial Differences in Stroke
BRIDGET
Erasmus Medical Center
Accelerating Medicines Partnership
National Institutes of Health-National Institute on Aging
Elan Pharmaceuticals, Inc.
public-private-philanthropic partnership
Rainwater Charitable Foundation
Health Research and Development
Eli Lilly and Company
Prospective Dementia Registry-Austria
Wellcome Trust
IXICO Ltd.
Arizona Alzheimer's Disease Core Center
Hussman Institute for Human Genomics Brain Bank
NeuroRx Research
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration
Merck & Co., Inc.
German Center for Neurodegenerative Diseases
Janssen Alzheimer Immunotherapy Research & Development, LLC
Austrian Research Promotion agency
Netherlands Genomics Initiative
Neurotrack Technologies
Fujirebio
Lundbeck
University of Toronto (UT)
Netherlands Organization of Scientific Research NWO Investments
Rotterdam Study
Eisai Inc.
National Institute on Aging Alzheimer's Disease Data Storage Site
FWCI
27.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals